載入中
NASDAQHealthcareMedical - Care Facilities
最新資料
US$31.07
+US$0.02 · +0.06%
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
前收盤價
US$31.07
+US$0.02 · +0.06%
盤中時間採用ET。市場資料可能有所延遲。
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
日內區間
目前US$31.07
52週區間
目前US$31.07
盤中時間採用ET。市場資料可能有所延遲。
Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
日內區間
目前US$31.07
52週區間
目前US$31.07
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 56.5億 USD | 49.98億 USD | 43.02億 USD | 39.45億 USD | 34.39億 USD |
| 銷貨成本 | 46.29億 USD | 39.85億 USD | 33.21億 USD | 30.78億 USD | 26.59億 USD |
| 毛利 | 10.2億 USD | 10.13億 USD | 9.81億 USD | 8.67億 USD | 7.8億 USD |
| 銷售、一般及管理費用 | 6.82億 USD | 6.3億 USD | 6.07億 USD | 5.66億 USD | 5.26億 USD |
| 營業費用 | 6.82億 USD | 6.91億 USD | 6.67億 USD | 6.27億 USD | 5.89億 USD |
| 利息支出 | 6319.6萬 USD | 6055.6萬 USD | 6222.2萬 USD | 5489.6萬 USD | 5546.4萬 USD |
| 折舊和攤銷 | 7069萬 USD | 6349.8萬 USD | 6220萬 USD | 6543.4萬 USD | 6880.4萬 USD |
| 營業利益 | 3.38億 USD | 3.22億 USD | 3.15億 USD | 2.4億 USD | 1.91億 USD |
| 淨利 | 2.08億 USD | 2.12億 USD | 2.67億 USD | 1.51億 USD | 1.4億 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
iShares Russell 2000 ETFIWM1.3億0.17%787.4億 USD0.19%US$278.94+0.49%
Vanguard Morningstar Total Stock Market ETFVTI1.17億0.00%2.3兆 USD0.03%US$381.94+0.63%
Vanguard Morningstar Small-Cap ETFVB8472.21萬0.05%1853億 USD0.03%US$289.48+0.64%
Dimensional - US Targeted Value ETFDFAT6343.63萬0.21%301.22億 USD0.33%US$67.27-0.43%
Fidelity Enhanced Small Cap ETFFESM5752.97萬0.88%64.1億 USD0.28%US$45.46+0.46%
Vanguard Morningstar Small-Cap Growth ETFVBK4872.72萬0.11%447億 USD0.05%US$344.74+1.22%
Dimensional - US Small Cap ETFDFAS4570.19萬0.14%338.69億 USD0.31%US$78.35+0.32%
Vanguard Extended Market ETFVXF4280.11萬0.04%954億 USD0.05%US$235+0.80%iShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBDimensional - US Targeted Value ETFDFATFidelity Enhanced Small Cap ETFFESMVanguard Morningstar Small-Cap Growth ETFVBKDimensional - US Small Cap ETFDFASVanguard Extended Market ETFVXFAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
